Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population.
Saved in:
| Title: | Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population. |
|---|---|
| Authors: | Freedland SJ; Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Urology Section, Durham VA Medical Center, Durham, NC, USA., Davis M; Medicus Economics, LLC, Milton, MA, USA., Epstein AJ; Medicus Economics, LLC, Milton, MA, USA., Arondekar B; Pfizer Inc., Collegeville, PA, USA., Ivanova JI; Pfizer Inc., New York, NY, USA. Jasmina.Ivanova@pfizer.com. |
| Source: | Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Jun; Vol. 27 (2), pp. 327-333. Date of Electronic Publication: 2023 Oct 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1476-5608 |
|---|---|
| DOI: | 10.1038/s41391-023-00725-8 |
